Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
6
Number of overlapping holdings
20.0%
% of MEDX's 30 holdings also in HRTS
15.4%
% of HRTS's 39 holdings also in MEDX
Overlap by Weight
Sector Drift (MEDX minus HRTS)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in MEDX |
Weight in HRTS |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 15.5% | 6.4% | 6.4% |
|
AMGEN INC | 5.9% | 5.1% | 5.1% |
|
ALNYLAM PHARMACEUTICALS INC | 4.2% | 4.7% | 4.2% |
|
REGENERON PHARMACEUTICALS | 3.4% | 2.4% | 2.4% |
|
IONIS PHARMACEUTICALS, INC. | 2.7% | 2.3% | 2.3% |
Position Highlights (Non-Overlapping Exposures)
MEDX Overweight Relative to HRTS
|
ELI LILLY & CO | 9.1% |
|
ABBVIE INC | 7.8% |
|
BRISTOL-MYERS SQUIBB CO | 6.2% |
 |
NOVARTIS AG-ADR | 6.1% |
 |
ASTRAZENECA PLC-SPONS ADR | 4.9% |
|
JOHNSON & JOHNSON | 4.9% |
 |
ALKERMES PLC | 4.0% |
|
MERCK & CO. INC. | 4.0% |
|
PFIZER INC | 4.0% |
|
BIOGEN IDEC INC | 3.1% |
MEDX Underweight Relative to HRTS
|
VERTEX PHARMACEUTICALS INC | -5.7% |
 |
CHUGAI PHARMACEUTICAL CO LTD | -3.9% |
|
CRINETICS PHARMACEUTICALS INC | -3.8% |
|
BRIDGEBIO PHARMA, INC. | -3.8% |
 |
NOVO NORDISK A/S-B | -3.6% |
|
CYTOKINETICS INC | -3.3% |
|
ASTRAZENECA PLC | -3.1% |
|
BOSTON SCIENTIFIC CORP | -3.1% |
|
ASCENDIS PHARMA A/S | -3.1% |
|
MEDTRONIC PLC | -3.0% |